Lebel Ehud, Weinberg Eliraz, Berenstein-Weyel Tamar M, Bromiker Ruben
aDepartment of Orthopedic Surgery, Pediatric Orthopedic ServicebPediatric Section, Department of Neonatology, Shaare Zedek Medical Center, Affiliated with the Hebrew-University School of Medicine, Jerusalem, Israel.
J Pediatr Orthop B. 2017 Mar;26(2):108-111. doi: 10.1097/BPB.0000000000000363.
The treatment of congenital clubfoot has been changing rapidly since the mid-1990s with the worldwide use of the Ponseti method for serial casting and limited operative interventions. This method was first applied for isolated clubfeet and later on for other types of clubfoot (teratologic, residual, and neurogenic). Premature babies sustaining clubfoot commonly suffer from additional congenital and acquired medical problems. These may postpone clubfoot management until urgent issues are resolved. The current study describes early initiation of treatment of clubfoot in premature babies at the neonatal intensive care unit (NICU) and their outcomes. The study group included all babies diagnosed with clubfoot and managed in the NICU (for any etiology) between 2006 and 2012. Management was based on the Ponseti protocol for serial casting. We also report on neonates who died in the NICU before or during treatment. We specifically describe adverse events of early casting and situations necessitating removal of casts or termination of treatment. We diagnosed and treated 20 neonates with clubfoot (four females and 16 males, 10 bilateral cases). Gestational age ranged from 27 weeks to term. Eight were identified with clubfoot by prenatal sonographic survey and 10 were diagnosed with a defined syndrome. Seven had respiratory support, including one with a chest drain (50%). Length of stay in the NICU ranged from 3 to 90 days. Four neonates died while in the NICU (all syndromatic). In the remaining 16 cases, treatment began as early as medically possible. The first cast was applied within the first week of life in 14 cases. A total of 75 casts were applied during the study period. Three casts (4%) were removed because of leg edema or a need for venous access. Casts were routinely replaced every 4-7 days. Achilles tenotomies were performed in the NICU for babies achieving satisfactory correction. At last follow-up, 10 children were independent walkers and six were nonambulatory; all showed successful correction of clubfeet. The results of this study show that in most cases, clubfoot treatment is feasible and effective within the first week of life. Instances necessitating immediate cast removal are highlighted. Although while facing acute life-threatening medical problems, the treatment of clubfoot may not be considered a priority, most neonates will grow up into independent individuals; thus, every effort should be made to initiate the best clubfoot management with minimal delay.
自20世纪90年代中期以来,随着庞塞蒂方法在全球范围内用于系列石膏固定和有限的手术干预,先天性马蹄内翻足的治疗方法一直在迅速变化。该方法最初用于单纯性马蹄内翻足,后来也用于其他类型的马蹄内翻足(畸形性、残留性和神经源性)。患有马蹄内翻足的早产儿通常还患有其他先天性和后天性医疗问题。这些问题可能会推迟马蹄内翻足的治疗,直到紧急问题得到解决。本研究描述了在新生儿重症监护病房(NICU)对早产儿早期开始治疗马蹄内翻足及其结果。研究组包括2006年至2012年间在NICU诊断为马蹄内翻足并接受治疗(任何病因)的所有婴儿。治疗基于庞塞蒂系列石膏固定方案。我们还报告了在NICU治疗前或治疗期间死亡的新生儿。我们特别描述了早期石膏固定的不良事件以及需要拆除石膏或终止治疗的情况。我们诊断并治疗了20例马蹄内翻足新生儿(4例女性和16例男性,10例双侧病例)。胎龄从27周至足月。8例通过产前超声检查确诊为马蹄内翻足,10例诊断为明确的综合征。7例需要呼吸支持,其中1例有胸腔引流管(50%)。在NICU的住院时间为3至90天。4例新生儿在NICU期间死亡(均患有综合征)。在其余16例中,治疗尽早在医学可行时开始。14例在出生后第一周内应用了第一副石膏。在研究期间共应用了75副石膏。3副石膏(4%)因腿部水肿或需要静脉通路而拆除。石膏常规每4至7天更换一次。对矫正满意的婴儿在NICU进行跟腱切断术。在最后一次随访时,10名儿童能够独立行走,6名不能行走;所有患儿马蹄内翻足均矫正成功。本研究结果表明,在大多数情况下,马蹄内翻足治疗在出生后第一周内是可行且有效的。突出了需要立即拆除石膏的情况。虽然面临急性危及生命的医疗问题时,马蹄内翻足治疗可能不被视为优先事项,但大多数新生儿将成长为独立个体;因此,应尽一切努力尽早开始最佳的马蹄内翻足治疗,尽量减少延误。